Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins

Alternative lengthening of telomeres (ALT) is a recombination-mediated process that maintains telomeres in telomerase-negative cancer cells. In asynchronously dividing ALT-positive cell populations, a small fraction of the cells have ALT-associated promyelocytic leukemia nuclear bodies (APBs), which contain (TTAGGG)n DNA and telomere-binding proteins. We found that restoring p53 function in ALT cells caused p21 up-regulation, growth arrest/senescence, and a large increase in cells containing APBs. Knockdown of p21 significantly reduced p53-mediated induction of APBs. Moreover, we found that heterochromatin protein 1 (HP1) is present in APBs, and knockdown of HP1α and/or HP1γ prevented p53-mediated APB induction, which suggests that HP1-mediated chromatin compaction is required for APB formation. Therefore, although the presence of APBs in a cell line or tumor is an excellent qualitative marker for ALT, the association of APBs with growth arrest/senescence and with “closed” telomeric chromatin, which is likely to repress recombination, suggests there is no simple correlation between ALT activity level and the number of APBs or APB-positive cells.

[1]  P. Salomoni,et al.  Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA , 2007, The Journal of cell biology.

[2]  R. Reddel,et al.  Disruption of Telomere Maintenance by Depletion of the MRE11/RAD50/NBS1 Complex in Cells That Use Alternative Lengthening of Telomeres* , 2007, Journal of Biological Chemistry.

[3]  R. Reddel,et al.  DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. , 2007, Cancer research.

[4]  R. Reddel,et al.  Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference , 2007, Oncogene.

[5]  Hongtao Yu,et al.  The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins , 2007, Nature Structural &Molecular Biology.

[6]  F. Ishikawa,et al.  Cellular senescence and chromatin structure , 2007, Chromosoma.

[7]  M. Blasco.  The epigenetic regulation of mammalian telomeres , 2007, Nature Reviews Genetics.

[8]  D. C. Schultz,et al.  The KAP1 Corepressor Functions To Coordinate the Assembly of De Novo HP1-Demarcated Microenvironments of Heterochromatin Required for KRAB Zinc Finger Protein-Mediated Transcriptional Repression , 2006, Molecular and Cellular Biology.

[9]  M. Mitchell,et al.  PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase , 2006, Journal of Cell Science.

[10]  H. Leonhardt,et al.  Spatiotemporal dynamics of p21CDKN1A protein recruitment to DNA-damage sites and interaction with proliferating cell nuclear antigen , 2006, Journal of Cell Science.

[11]  M. Fraga,et al.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.

[12]  H. Bergmeister,et al.  Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. , 2006, Cancer research.

[13]  Anindya Dutta,et al.  PCNA Is a Cofactor for Cdt1 Degradation by CUL4/DDB1-mediated N-terminal Ubiquitination* , 2006, Journal of Biological Chemistry.

[14]  J. Royds,et al.  Y-box factor YB1 controls p53 apoptotic function , 2005, Oncogene.

[15]  M. Cerone,et al.  A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT , 2005, Oncogene.

[16]  R. Reddel,et al.  The first molecular details of ALT in human tumor cells. , 2005, Human molecular genetics.

[17]  R. Reddel,et al.  Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex , 2005, Molecular and Cellular Biology.

[18]  Manel Esteller,et al.  Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin , 2005, Nature Cell Biology.

[19]  R. Reddel,et al.  Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. , 2005, Cancer research.

[20]  L. Guarente,et al.  A novel telomere structure in a human alternative lengthening of telomeres cell line. , 2005, Cancer research.

[21]  R. Reddel,et al.  hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere , 2005, Nucleic acids research.

[22]  Mina J Bissell,et al.  Higher-order nuclear organization in growth arrest of human mammary epithelial cells: a novel role for telomere-associated protein TIN2 , 2004, Journal of Cell Science.

[23]  Adrian A Canutescu,et al.  Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. , 2005, Developmental cell.

[24]  Dihua Yu,et al.  A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  Osamu Iwasaki,et al.  A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1 , 2004, Nature Cell Biology.

[26]  Frank Eisenhaber,et al.  Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. , 2004, Genes & development.

[27]  W. Engels,et al.  The Drosophila Mre11/Rad50 Complex Is Required to Prevent Both Telomeric Fusion and Chromosome Breakage , 2004, Current Biology.

[28]  J. Testa,et al.  p53 Differentially Inhibits Cell Growth Depending on the Mechanism of Telomere Maintenance , 2004, Molecular and Cellular Biology.

[29]  F. Ishikawa,et al.  Localization of hRad9, hHus1, hRad1, and hRad17 and Caffeine-sensitive DNA Replication at the Alternative Lengthening of Telomeres-associated Promyelocytic Leukemia Body* , 2004, Journal of Biological Chemistry.

[30]  S. West,et al.  Telomere Maintenance Requires the RAD51D Recombination/Repair Protein , 2004, Cell.

[31]  W. Reik,et al.  Chromosomal localization of human homologs of the Drosophila heterochromatin protein 1 (HP1) gene , 2004, Mammalian Genome.

[32]  T. Jenuwein,et al.  Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases , 2004, Nature Genetics.

[33]  Roland Eils,et al.  Visualizing telomere dynamics in living mammalian cells using PNA probes , 2003, The EMBO journal.

[34]  M. Mann,et al.  ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. , 2003, Molecular cell.

[35]  T. Pandita,et al.  Human Heterochromatin Protein 1 Isoforms HP1Hsα and HP1Hsβ Interfere with hTERT-Telomere Interactions and Correlate with Changes in Cell Growth and Response to Ionizing Radiation , 2003, Molecular and Cellular Biology.

[36]  Phang-lang Chen,et al.  Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. , 2003, Cancer research.

[37]  M. Ikura,et al.  The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. , 2002, Human molecular genetics.

[38]  E. Gilson,et al.  Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity , 2002, EMBO reports.

[39]  Annick Harel-Bellan,et al.  Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways , 2002 .

[40]  R. Reddel,et al.  Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.

[41]  R. Reddel,et al.  Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit , 2002, Oncogene.

[42]  T. de Lange.  Protection of mammalian telomeres , 2002, Oncogene.

[43]  S. Bohlander,et al.  SALL1, the gene mutated in Townes-Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin. , 2001, Human molecular genetics.

[44]  K Weber,et al.  Identification of essential genes in cultured mammalian cells using small interfering RNAs. , 2001, Journal of cell science.

[45]  R. Reddel,et al.  Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells , 2001, Molecular and Cellular Biology.

[46]  Karl Mechtler,et al.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins , 2001, Nature.

[47]  M. McVey,et al.  The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase , 2001, The EMBO journal.

[48]  H. Worman,et al.  Expression and functional analysis of three isoforms of human heterochromatin-associated protein HP1 in Drosophila , 2001, Chromosoma.

[49]  A. Godwin,et al.  ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. , 2000, Journal of cell science.

[50]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[51]  P. L. Chen,et al.  NBS1 and TRF1 Colocalize at Promyelocytic Leukemia Bodies during Late S/G2 Phases in Immortalized Telomerase-negative Cells , 2000, The Journal of Biological Chemistry.

[52]  S. Lowe,et al.  PML is induced by oncogenic ras and promotes premature senescence. , 2000, Genes & development.

[53]  G. Dotto,et al.  p21(WAF1/Cip1): more than a break to the cell cycle? , 2000, Biochimica et biophysica acta.

[54]  Pier Paolo Pandolfi,et al.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.

[55]  Matthias Mann,et al.  Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres , 2000, Nature Genetics.

[56]  L. Guarente,et al.  Nuclear structure in normal and Bloom syndrome cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Elgin,et al.  The HP1 protein family: getting a grip on chromatin. , 2000, Current opinion in genetics & development.

[58]  R. Perez-soler,et al.  Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells. , 2000, Anticancer research.

[59]  R. Reddel.  The role of senescence and immortalization in carcinogenesis. , 2000, Carcinogenesis.

[60]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[61]  R. Reddel,et al.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.

[62]  I. Roninson,et al.  Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs , 1999, Oncogene.

[63]  J. Roth,et al.  Overexpression of the p21 sdi1 gene induces senescence-like state in human cancer cells: implication for senescence-directed molecular therapy for cancer , 1999, Cell Death and Differentiation.

[64]  Sam W. Lee,et al.  p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53 , 1999, Oncogene.

[65]  D. Givol,et al.  Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin , 1999, Oncogene.

[66]  A. Dejean,et al.  Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  M. Haas,et al.  Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[68]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[69]  S. Aaronson,et al.  Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Wenyi Wei,et al.  Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. , 1997, Science.

[71]  N. Ringertz,et al.  Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[72]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[73]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[74]  R. Reddel,et al.  Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts , 1995, Molecular and cellular biology.

[75]  G. Hannon,et al.  Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair , 1994, Nature.

[76]  J. Murnane,et al.  Telomere dynamics in an immortal human cell line. , 1994, The EMBO journal.

[77]  R. Reddel,et al.  In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants. , 1994, Oncogene.

[78]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[79]  R. Reddel,et al.  Germ-line splicing mutation of the p53 gene in a cancer-prone family. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[80]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.